‍

Dear Foregen community,

‍

As we look back on a successful 2024, let’s highlight the significant progress we’ve made in our research and organizational development. Here's an overview of what we've accomplished:

Research Progress

We completed the final rounds of sheep trials, a critical step in moving forward to human trials. All necessary tissue samples for the HistologiX histology study have been secured, allowing us to proceed with the analysis. Additionally, we've commissioned Dr. Jose Vega to conduct new research on the foreskin’s nerve structures, which will also inform our approach to human trials.

‍

Organizational Development

The addition of Clinical Project Manager Beatrix Szebeni-Varga strengthens our capacity to prepare for human trials. Her expertise will be essential as we develop protocols and establish research parameters. We're also currently in discussions with several potential research partners who could provide key support during both the preparation and execution phases of human trials.

‍

Looking Forward

As we move into 2025, we are focused on planning and preparing for human clinical trials. For a detailed understanding of what this entails, we've published a comprehensive overview on our YouTube channel. We are excited to update about our exciting progress along the way!

‍

Fundraising

Thanks to your incredible generosity, our fundraising efforts yielded $110,335 across all platforms in December! This included the ongoing GoFundMe campaign to support human clinical trials. This funding enables us to proceed with crucial preparatory work!

Sincerely,

Ryan Jones

Chief Operations Officer

Foregen